{
    "Trade/Device Name(s)": [
        "ARCHITECT iPhenytoin Immunoassay",
        "ARCHITECT iPhenytoin Calibrators (A-F)"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K080696",
    "Predicate Device Reference 510(k) Number(s)": [
        "K935375"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LGR",
        "DLJ"
    ],
    "Summary Letter Date": "August 25, 2008",
    "Summary Letter Received Date": "August 26, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3350",
        "21 CFR 862.3200"
    ],
    "Regulation Name(s)": [
        "Diphenylhydantoin test system",
        "Calibrator, drug specific"
    ],
    "Analyte Class(es)": [
        "tdm",
        "toxicology"
    ],
    "Analyte(s)": [
        "Phenytoin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": "",
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT iPhenytoin Immunoassay and Calibrators for quantitative measurement of phenytoin in human serum or plasma using CMIA technology",
    "Indications for Use Summary": "For quantitative measurement of phenytoin in human serum or plasma to monitor phenytoin levels and ensure appropriate therapy using the ARCHITECT i System",
    "fda_folder": "Toxicology"
}